Newsy's Latest Health News

The video discusses recent developments in COVID-19 clinical trials. Eli Lilly's antibody treatment trial was paused due to safety concerns, with no specific reason provided. Johnson & Johnson also paused their vaccine trial after a participant experienced an unexplained illness. Meanwhile, Pfizer received FDA approval to include children as young as 12 in their vaccine trials, expanding from previous trials with older adolescents. The video highlights the potential for children to spread COVID-19 to adults, despite often having mild or no symptoms themselves.

Why was Eli Lilly's clinical trial for its coronavirus antibody treatment paused?

• Due to a lack of participants

• Because of potential safety concerns

• The trial was completed

• The treatment was ineffective

What caused Johnson to pause its phase three COVID-19 vaccine trials?

• Regulatory issues

• Lack of funding

• The vaccine was ineffective

• A participant had an unexplained illness

At what age did Pfizer receive FDA approval to start enrolling children in their vaccine trials?

• 16 years old

• 14 years old

• 12 years old

• 10 years old

What is a potential risk of children spreading COVID-19 to adults?

• Children cannot spread the virus to adults

• Adults are immune to the virus

• Adults may have stronger reactions, including death

• Adults may experience milder symptoms

To what age group did Pfizer expand its vaccine trials last month?

• Children as young as 10

• Seniors over 65

• Adolescents as young as 16

• Adults over 30